<i>AJRCCM</i>: 100-Y<scp>ear</scp> A<scp>nniversary</scp>.Homeward Bound: A Centenary of Home Mechanical Ventilation

Hind, Matthew; Polkey, Michael I.; Simonds, Anita K.

doi:10.1164/rccm.201702-0285ci

Cited by 29 publications

(30 citation statements)

References 91 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Non-invasive ventilation (NIV) is the application of ventilatory support via a non-invasive interface instead of an endotracheal tube or tracheostomy. Following early mechanical ventilation applications as negative pressure ventilation in the 1930s, the use of NIV in children has increased exponentially around the world in recent years (1)(2)(3). There are many studies showing the benefits and superiority of NIV in comparison with invasive ventilation via tracheostomy in terms of quality of life, health care costs, and morbidity (4,5).…”

Section: Introductionmentioning

confidence: 99%

Non-invasive Ventilation for Children With Chronic Lung Disease

2020

View full text Add to dashboard Cite

Advances in medical care and supportive care options have contributed to the survival of children with complex disorders, including children with chronic lung disease. By delivering a positive pressure or a volume during the patient's inspiration, NIV is able to reverse nocturnal alveolar hypoventilation in patients who experience hypoventilation during sleep, such as patients with chronic lung disease. Bronchopulmonary dysplasia (BPD) is a common complication of prematurity, and despite significant advances in neonatal care over recent decades its incidence has not diminished. Most affected infants have mild disease and require a short period of oxygen supplementation or respiratory support. However, severely affected infants can become dependent on positive pressure support for a prolonged period. In case of established severe BPD, respiratory support with non-invasive or invasive positive pressure ventilation is required. Patients with cystic fibrosis (CF) and advanced lung disease develop hypoxaemia and hypercapnia during sleep and hypoventilation during sleep usually predates daytime hypercapnia. Hypoxaemia and hypercapnia indicates poor prognosis and prompts referral for lung transplantation. The prevention of respiratory failure during sleep in CF may prolong survival. Long-term oxygen therapy has not been shown to improve survival in people with CF. A Cochrane review on the use NIV in CF concluded that NIV in combination with oxygen therapy improves gas exchange during sleep to a greater extent than oxygen therapy alone in people with moderate to severe CF lung disease. Uncontrolled, non-randomized studies suggest survival benefit with NIV in addition to being an effective bridge to transplantation. Complications of NIV relate mainly to prolonged use of a face or nasal mask which can lead to skin trauma, and neurodevelopmental delay by acting as a physical barrier to social interaction. Another associated risk is pulmonary aspiration caused by vomiting whilst wearing a face mask. Adherence to NIV is one of the major barriers to treatment in children. This article will review the current evidence for indications, adverse effects and long term follow up including adherence to NIV in children with chronic lung disease.

show abstract

Section: Introductionmentioning

confidence: 99%

Non-invasive Ventilation for Children With Chronic Lung Disease

2020

View full text Add to dashboard Cite

show abstract

“…The key indication for HMV is chronic ventilatory insufficiency [5,6]. This may arise from NMD, obstructive airway diseases, or obesity-related respiratory failure.…”

Section: Introductionmentioning

confidence: 99%

“…This may arise from NMD, obstructive airway diseases, or obesity-related respiratory failure. However, with advances in critical care management, there is an increasing number of patients who survive acute respiratory failure (e.g., due to acute respiratory distress syndrome), and some of them are required to use HMV [5]. Furthermore, as the population ages, the need for ongoing mechanical ventilation in the home or in long-term care facilities is likely to increase.…”

Section: Introductionmentioning

confidence: 99%

Home mechanical ventilation: back to basics

Park

Suh

2020

Acute Crit Care

View full text Add to dashboard Cite

Home mechanical ventilation: back to basics Over recent decades, the use of home mechanical ventilation (HMV) has steadily increased worldwide, with varying prevalence in different countries. The key indication for HMV is chronic respiratory failure with alveolar hypoventilation (e.g., neuromuscular and chest wall disease, obstructive airway diseases, and obesity-related respiratory failure). Most modern home ventilators are pressure-targeted and have sophisticated modes, alarms, and graphics, thereby facilitating optimization of the ventilator settings. However, different ventilators have different algorithms for tidal volume estimation and leak compensation, and there are also several different circuit configurations. Hence, a basic understanding of the fundamentals of HMV is of paramount importance to healthcare workers taking care of patients with HMV. When choosing a home ventilator, they should take into account many factors, including the current condition and prognosis of the primary disease, the patient's daily performance status, time (hr/day) needed for ventilator support, family support, and financial costs. In this review, to help readers understand the basic concepts of HMV use, we describe the indications for HMV and the factors that influence successful delivery, including interface, circuits, ventilator accessories, and the ventilator itself.

show abstract

“…The use of non-invasive positive pressure ventilation (NPPV) has become common and, in many cases, the first choice for mechanical ventilation worldwide. [1][2][3][4][5] In China, the majority of tertiary hospitals are equipped with NPPV ventilators; however, there is an imbalance of resources between different regions and hospitals (see Appendix S1, Supplementary Information, for the history and development of NPPV for respiratory failure in China). There is also a disparity in the economic, scientific and technological uptake among countries of the Asia-Pacific region, with many still developing economically.…”

Section: Introductionmentioning

confidence: 99%

Challenges to and opportunities for the implementation of non‐invasive positive pressure ventilation in the Asia‐Pacific region

et al. 2019

View full text Add to dashboard Cite

Non‐invasive positive pressure ventilation (NPPV) is undoubtedly one of the most significant advancements in mechanical ventilation technology in the past 30 years. With accumulating evidence from clinical studies and support from clinical guidelines, NPPV is now widely used in hospitals and increasingly prescribed for home therapy in the Asia‐Pacific region. However, in comparison with the developed Western countries, overall use of NPPV in the region is lagging behind. This study reviews this imbalance of NPPV use both in the acute and domiciliary settings in the Asia‐Pacific region. Important issues related to NPPV use are also discussed along with speculation around potential strategies that could promote wider implementation of NPPV in the region. We hope this review will stimulate interest in the clinical application and potential research avenues for NPPV in the Asia‐Pacific region, and promote education and staff training in the technique.

show abstract

AJRCCM: 100-Year Anniversary.Homeward Bound: A Centenary of Home Mechanical Ventilation

Cited by 29 publications

References 91 publications

Non-invasive Ventilation for Children With Chronic Lung Disease

Non-invasive Ventilation for Children With Chronic Lung Disease

Home mechanical ventilation: back to basics

Challenges to and opportunities for the implementation of non‐invasive positive pressure ventilation in the Asia‐Pacific region

Contact Info

Product

Resources

About